News Sentiment

ZEAL sentiment intelligence

Zealand Pharma A/S news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 52 Balanced news tone 17 relevant articles
Exchange CPH Denmark
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 295.40 Week of 17 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

89/100 classification confidence.

Company focus 17

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+4.8% over one week, +5.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Zealand Pharma (CPSE:ZEAL) Stock Stays Reasonable On Earnings Yet Richer On Fair Value

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 89/100 classification
One-week reaction 4.8% Price confirming higher
Trend fit Trend inactive 5.3% over four weeks
Fair value -42.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 12
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 17
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
simplywall.st 6
Bloomberg.com 1
MarketBeat 1

Event Lens

What the news is about

Classified themes
Market update 14
Earnings 2
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-17 of 17